Open Access
| Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
|---|---|---|
| Article Number | 03007 | |
| Number of page(s) | 4 | |
| Section | Medical Testing and Health Technology Integration | |
| DOI | https://doi.org/10.1051/bioconf/202411103007 | |
| Published online | 31 May 2024 | |
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021, 71 (3), 209–249. [CrossRef] [PubMed] [Google Scholar]
- Collaborators, G. B. D. S. C. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol 2020, 5 (1), 42–54 [CrossRef] [PubMed] [Google Scholar]
- Sitarz, R.; Skierucha, M.; Mielko, J.; Offerhaus, G.J.A.; Maciejewski, R.; Polkowski, W.P. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018, 10, 239–248. [CrossRef] [Google Scholar]
- Ebrahimi, V.; Soleimanian, A.; Ebrahimi, T.; Azargun, R.; Yazdani, P.; Eyvazi, S.; Tarhriz, V. Epigenetic modifications in gastric cancer: Focus on DNA methylation. Gene 2020, 742, 144577. [CrossRef] [PubMed] [Google Scholar]
- Qu, Y.; Dang, S.; Hou, P. Gene methylation in gastric cancer. Clin Chim Acta 2013, 424, 53–65. [CrossRef] [PubMed] [Google Scholar]
- Ganesan, A.; Arimondo, P.B.; Rots, M.G.; Jeronimo, C.; Berdasco, M. The timeline of epigenetic drug discovery: from reality to dreams. Clin Epigenetics 2019, 11 (1), 174. [CrossRef] [PubMed] [Google Scholar]
- Hu, M.; Sun, X.J.; Zhang, Y.L.; Kuang, Y.; Hu, C.Q.; Wu, W.L.; Shen, S.H.; Du, T.T.; Li, H.; He, F.; et al. Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. Proc Natl Acad Sci U S A 2010, 107 (7), 2956–2961. [CrossRef] [PubMed] [Google Scholar]
- Cerami, E.; Gao, J.; Dogrusoz, U.; Gross, B.E.; Sumer, S.O.; Aksoy, B.A.; Jacobsen, A.; Byrne, C.J.; Heuer, M.L.; Larsson, E.; et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012, 2 (5), 401–404. [CrossRef] [PubMed] [Google Scholar]
- He, J.; Xu, T.; Zhao, F.; Guo, J.; Hu, Q. SETD2-H3K36ME3: an important bridge between the environment and tumors. Front Genet 2023, 14, 1204463. [CrossRef] [PubMed] [Google Scholar]
- Chen, Z.; Raghoonundun, C.; Chen, W.; Zhang, Y.; Tang, W.; Fan, X.; Shi, X. SETD2 indicates favorable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion. Biochem Biophys Res Commun 2018, 498 (3), 579–585. [CrossRef] [PubMed] [Google Scholar]
- Vishnoi, K.; Viswakarma, N.; Rana, A.; Rana, B. Transcription Factors in Cancer Development and Therapy. Cancers (Basel) 2020, 12 (8). [Google Scholar]
- Elbadawy, M.; Usui, T.; Yamawaki, H.; Sasaki, K. Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer. Int J Mol Sci 2019, 20 (9). [Google Scholar]
- Zhang, L.; Hou, Y.; Ashktorab, H.; Gao, L.; Xu, Y.; Wu, K.; Zhai, J.; Zhang, L. The impact of C-MYC gene expression on gastric cancer cells. Mol Cell Biochem 2010, 344 (1-2), 125–135. [CrossRef] [PubMed] [Google Scholar]
- Milne, A. N.; Sitarz, R.; Carvalho, R.; Carneiro, F.; Offerhaus, G.J. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med 2007, 7 (1), 15–28. [CrossRef] [PubMed] [Google Scholar]
- Gao, S.; Chen, M.; Wei, W.; Zhang, X.; Zhang, M.; Yao, Y.; Lv, Y.; Ling, T.; Wang, L.; Zou, X. Crosstalk of mTOR/PKM2 and STAT3/c-Myc signaling pathways regulate the energy metabolism and acidic microenvironment of gastric cancer. J Cell Biochem 2019, 120 (2), 1193–1202. [CrossRef] [PubMed] [Google Scholar]
- Liu, J.; Feng, W.; Liu, M.; Rao, H.; Li, X.; Teng, Y.; Yang, X.; Xu, J.; Gao, W.; Li, L. Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling. Bosn J Basic Med Sci 2021, 21 (4), 434–446. [PubMed] [Google Scholar]
- Lei, Z. N.; Teng, Q.X.; Tian, Q.; Chen, W.; Xie, Y.; Wu, K.; Zeng, Q.; Zeng, L.; Pan, Y.; Chen, Z.S.; He, Y. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther 2022, 7 (1), 358. [CrossRef] [PubMed] [Google Scholar]
- Fattahi, S.; Amjadi-Moheb, F.; Tabaripour, R.; Ashrafi, G.H.; Akhavan-Niaki, H. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci 2020, 262, 118513. [CrossRef] [PubMed] [Google Scholar]
- Song, Y.; Li, Z.X.; Liu, X.; Wang, R.; Li, L.W.; Zhang, Q. The Wnt/beta-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation. Tumour Biol 2017, 39 (7), 1010428317712617. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.